Biotechnology company
Issues related to Medicare and Medicaid coverage and reimbursement; the 340B Drug Discount Program; drug pricing Issues related to the 340B Drug Discount Program; drug pricing Issues and legislation relating to the development of policies to advance antimicrobial research, antiviral research, and novel product development environment, including advancing new market incentives. General education about policies impacting pharmaceutical development, approval, reimbursement and pricing. Issues related to healthcare legislation Issues related to health equity and clinical trial diversity Issues relating to privacy and securing the data of and personal information of consumers Issues relating to medical research data Issues related to public health preparedness and response
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
RIVENDELL GROUP LLP
1440 G Street, NW, Washington, DC, 20005, US
NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo) MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch) NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo) MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch)
LA and Counsel, Rep. Anna Eshoo LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch LA and Counsel, Rep. Anna Eshoo LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch